Fact Based List:
D2: 7 Key Factors Impacting Value-Based Contracting Between Plans/PBMs and Pharma or Medical Device Manufacturers
Submitted by Anonymous on Tue, 07/31/2018 - 13:39
- New, emerging technologies without competitive threats should provide data and enable a “little educated risk” to achieve better payer coverage and long term growth with value-based contracts.
- To reduce risk, develop a deep understanding and insights on how payers are using analytics or reporting related to value based contracting.
- Understand how new payment models for payers and providers are impacting the way manufacturers need to approach pricing, contracting and patient support services.
- Identify realistic, actionable yearly data metrics or supplemental data captured by technologies in contracting arrangements.
- Analyze, differentiate a new business model to get a seat at the table and successfully interact with a payer’s expectations for value-based arrangements.
- Be prepared to discuss “overpriced specialty drugs” and value-based contracting coverage.
- Align incentives between manufacturers and payers to best drive appropriate patient outcomes.
Source: D2 Consulting
Source URL: https://www.businesswire.com/news/home/20180717005077/en
List Ratings: |
Lists You Might Also Be Interested In
- 3 PBMs Partnered with Mark Cuban's Cost Plus Drug Company
- Precedence Research: PBM Market Size, 2021 to 2030
- PCMA: 9 Ways PBMs Improve Clinical Outcomes and Create Sustainable Pharmacy Benefits
- Five Ways for Employers to Contain PBM Prescription Costs: Employer Benefit News
- Employee Benefit News: Top 10 Ways to Evaluate a PBM
Login or register to post comments